Yamagata University · Faculty of Medicine

Research keywordsrenal cell carcinoma・metastatic RCC・prognostic models・immune checkpoint therapy・mTOR signaling・eIF4E pathway・FGFR4・urinary dysfunction

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Dynamic changes in myeloid cells in urological cancer patients during immune checkpoint treatment，CANCER SCIENCE，112 837，2021年02月2021 · Kato Tomoyuki, Takeda Yuji, Naito Sei, Ito Hiromi, Ushijima Masaki, Narisawa Takafumi, Yagi Mayu, Kanno Hidenori, Sakurai Toshihiko, Yamanobe Takuya, Asao Hironobu, Tsuchiya Norihiko
• Clinical utility of head computed tomography scan during systemic therapy for metastatic renal cell carcinoma，INTERNATIONAL JOURNAL OF UROLOGY，2021年02月2021 · Naito Sei, Narisawa Takafumi, Kato Tomoyuki, Ichiyanagi Osamu, Kurokawa Masayuki, Yagi Mayu, Kanno Hidenori, Kurota Yuta, Yamagishi Atsushi, Sakurai Toshihiko, Nishida Hayato, Yamanobe Takuya, Tsuchiy...
• Post-operative prediction of late recurrence of localized clear cell RCC using clinical models already reported，CANCER SCIENCE，112 835，2021年02月2021 · Ichiyanagi Osamu, Naito Sei, Narisawa Takafumi, Yagi Mayu, Kanno Hidenori, Sakurai Toshihiko, Ito Hiromi, Kato Tomoyuki, Tsuchiya Norihiko
• 同時性転移性腎細胞癌の新規予後モデル(New prognostic model for synchronous metastatic renal cell carcinoma)，International Journal of Urology，27(5) 448-456，2020年05月2020 · Naito Sei, Kato Tomoyuki, Ichiyanagi Osamu, Narisawa Takafumi, Kurokawa Masayuki, Yagi Mayu, Ushijima Masaki, Ozawa Michinobu, Kanno Hidenori, Kurota Yuta, Fukuhara Hiroki, Kuboki Yuya, Yamagishi Atsu...

• 若手研究，2022年04月 ～ 2024年03月，腎癌薬剤耐性獲得におけるBCL2A1の機能解析と新規治療戦略の開発2022

• Official profile